保健医学研究与实践2025，Vol.22Issue(1)：14-19,47,7.DOI:10.11986/j.issn.1673-873X.2025.01.03
全科医师对代谢相关脂肪性肝病的认知、态度及行为调查
A survey on knowledge,attitudes,and practices of general practitioners towards metabolic-associated fatty liver disease
摘要
Abstract
Objective To assess the knowledge,attitudes,and practices of general practitioners(GP)in Zhejiang Province regarding metabolic-associated fatty liver disease(MAFLD)and identify influencing factors.Methods A questionnaire sur-vey was conducted among 568 GPs in Zhejiang Province to collect data on their general information and their knowledge,at-titudes,and practices towards MAFLD.Univariate analysis was used to explore factors influencing GP's knowledge,atti-tudes,and practices.Results Overall,96.3%of GPs were aware of non-alcoholic fatty liver disease(NAFLD),and 86.0%aware of MAFLD,but only 48.4%were aware that NAFLD had been renamed MAFLD.According to Bloom's cri-teria,only 0.9%of GPs had good scores in knowledge.The lowest three items in knowledge scores were in MAFLD diag-nosis(4.2%),treatment(15.0%),and management/follow-up(15.7%).A total of 90.0%of GPs had good scores in at-titude,and 77.8%had good scores in practice.Differences in attitude and practice scores among GPs of different ages were statistically significant(P<0.05).GPs who had received MAFLD-related training had significantly higher scores in terms of knowledge and practice than those who had not(P<0.05).Correlation analysis showed significant positive correlations between knowledge and attitudes,knowledge and practices,and attitudes and practices(P<0.05).Conclusion GPs have positive attitudes and practices towards MAFLD but lack sufficient knowledge.To maximize their role as health gatekeep-ers,it is essential to design and implement targeted continuing education on MAFLD for GPs.关键词
全科医师/代谢相关脂肪性肝病/知信行Key words
General practitioners/Metabolic-associated fatty liver disease/Knowledge,attitudes,and practices分类
医药卫生引用本文复制引用
任文,孙雨菁,郑旸,李帅,陈明敏,任菁菁..全科医师对代谢相关脂肪性肝病的认知、态度及行为调查[J].保健医学研究与实践,2025,22(1):14-19,47,7.基金项目
浙江省医药卫生科技课题(2022KY758). （2022KY758）
